JAK inhibitors are linked to a higher risk for venous thromboembolism than TNF antagonists in immune-mediated inflammatory diseases, with no significant difference in serious infection or cancer risk.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/jak-inhibitor-vs-tnf-antagonist-which-safer-patients-immune-2025a1000o7b?src=rss
Author :
Publish date : 2025-09-12 11:43:00
Copyright for syndicated content belongs to the linked Source.
